Rapid case finding to connect people with HIV and Kaposi sarcoma to care in East Africa
Project 2: Rapid Case Ascertainment as a Tool for Epidemiologic Investigation and Efficient Linkage to Care in HIV-infected Patients Diagnosed with Kaposi Sarcoma in East Africa
This project works to find people with HIV who develop Kaposi sarcoma more quickly and help them get into medical care sooner.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11416317 on NIH RePORTER |
What this research studies
From a patient's point of view, the team will set up ways to quickly identify new Kaposi sarcoma cases at clinics and hospitals and gather basic information to guide care. Clinic staff, medical records, and community links may be used to speed diagnosis and referrals. The project will help patients get connected to HIV and cancer treatment services faster and follow their progress. The team will also look at patterns in the data to improve how care is organized across participating sites in East Africa.
Who could benefit from this research
Good fit: People living with HIV in East Africa who have a new or suspected diagnosis of Kaposi sarcoma at participating clinics would be the ideal candidates.
Not a fit: People who live outside the participating East African regions or who do not attend participating clinics are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, people with HIV and Kaposi sarcoma could be diagnosed and started on treatment sooner, which may improve health and survival.
How similar studies have performed: Active case-finding and linkage-to-care programs have improved HIV outcomes in other settings, but applying these approaches specifically for Kaposi sarcoma in East Africa is less common and is being tested here.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Byakwaga, Helen — University of California, San Francisco
- Study coordinator: Byakwaga, Helen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.